CPT® Code 38204

1. Indications

The procedure associated with CPT® Code 38204 is indicated for the following conditions:

• Hematologic Disorders Patients suffering from conditions such as leukemia, lymphoma, or other blood-related diseases that necessitate a hematopoietic stem cell transplant.
• Bone Marrow Failure Syndromes Individuals with aplastic anemia or myelodysplastic syndromes who require donor stem cells to restore normal blood cell production.
• Genetic Disorders Patients with inherited blood disorders, such as sickle cell disease or thalassemia, who may benefit from a stem cell transplant to correct the underlying genetic defect.

2. Procedure

The procedure for CPT® Code 38204 involves several critical steps to ensure the successful management of the donor search and cell acquisition:

• Step 1: Donor Search Management This initial step includes identifying potential donors through various registries and databases. Healthcare professionals coordinate with donor registries to find suitable matches based on the recipient's human leukocyte antigen (HLA) typing, which is crucial for transplant compatibility.
• Step 2: Donor Evaluation Once potential donors are identified, they undergo a thorough medical evaluation to assess their health status and suitability for donation. This evaluation includes reviewing medical history, conducting physical examinations, and performing necessary laboratory tests to ensure the donor's safety and the quality of the cells to be harvested.
• Step 3: Cell Acquisition Coordination After a suitable donor is confirmed, the next step involves coordinating the logistics of cell acquisition. This includes scheduling the collection procedure, which may involve either apheresis (for peripheral blood stem cells) or bone marrow harvest, and ensuring that all necessary medical personnel and equipment are in place for the procedure.
• Step 4: Collection of Hematopoietic Progenitor Cells The actual collection of cells is performed under sterile conditions. For peripheral blood stem cells, the donor may receive mobilizing agents prior to the collection to increase the number of stem cells in circulation. For bone marrow collection, the procedure is typically performed under anesthesia, and bone marrow is extracted from the donor's pelvic bone.
• Step 5: Transportation and Processing After collection, the hematopoietic progenitor cells are processed and prepared for transportation to the recipient's treatment facility. This step is critical to ensure that the cells remain viable and effective for transplantation.

3. Post-Procedure

Post-procedure care following the acquisition of hematopoietic progenitor cells involves monitoring both the donor and the recipient. The donor may experience some discomfort or side effects from the collection process, which should be managed appropriately. For the recipient, the cells are typically infused in a controlled clinical setting, and post-transplant care includes monitoring for potential complications such as graft-versus-host disease (GVHD) and ensuring the recipient's recovery and engraftment of the transplanted cells. Continuous follow-up is essential to assess the success of the transplant and manage any long-term effects.